Why wasn’t Joe Biden’s ‘aggressive’ prostate cancer spotted sooner? Experts weigh in
The recent late-stage cancer diagnosis of former U.S. president Joe Biden has shocked many, especially given the intense scrutiny his health was under during his presidency. Biden, 82, has been diagnosed with Stage 4 prostate cancer that has spread to the bone. This aggressive form of cancer, with a Gleason score of 9, is considered to be among the most advanced.
Prostate cancer, which starts in the cells of the prostate gland, can grow into nearby tissues and spread to other parts of the body. Symptoms can vary, with some individuals experiencing trouble urinating or blood in the urine. However, in many cases, there are no noticeable symptoms at all. This makes early detection challenging.
Prostate cancer is the most common cancer among Canadian men, with an estimated 27,900 new cases expected in 2024. Screening for prostate cancer typically involves a prostate-specific antigen (PSA) blood test or a digital rectal exam (DRE). While screening can help detect early signs of the disease, there is ongoing debate about the benefits and risks of these tests.
Given the lack of obvious symptoms and the limitations of current screening methods, it is not surprising that Biden’s cancer went undetected until now. Despite undergoing regular physical examinations, the chaotic nature of cancer cells can sometimes evade detection.
Treatment for prostate cancer varies depending on the stage and aggressiveness of the disease. For early-stage cancer, monitoring may be sufficient, as the cancer may not be harmful. In cases where the cancer is more advanced, treatments such as surgery, radiation, and hormone therapy are typically recommended.
Biden’s treatment plan will likely involve a combination of radiation and hormone therapy to slow the growth of the cancer cells. While these treatments can be effective initially, the long-term prognosis for Stage 4 prostate cancer is less optimistic. The five-year survival rate for Stage 4 prostate cancer is only 41%, highlighting the challenges that lie ahead for Biden.
As the world waits for updates on Biden’s health, the focus remains on raising awareness about prostate cancer and the importance of regular screening for early detection. While the road ahead may be challenging for Biden, he is not alone in his fight against this devastating disease.
